Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Orally active antiplatelet agents disclosed by Mitsui Toatsu

April 22, 1997

Stable prostacyclins disclosed by Asahi Glass

April 21, 1997

Factor Xa inhibitors from Boehringer Mannheim

April 18, 1997

New fibrinogen antagonist from DuPont Merck

April 17, 1997

DuPont Merck presents new thrombin inhibitor

April 17, 1997

Novel aggregation pathway identified

April 16, 1997

Roberts' Agrylin available today in U.S.

April 14, 1997

FK-633 inhibits thrombosis and prevents restenosis in hamster model

April 14, 1997

Integrilin MAA withdrawn; companies await PURSUIT results

April 14, 1997

Genentech granted U.S. patents for factor VIII

April 11, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...